Ansa Biotechnologies logo

Ansa Biotechnologies

Challenger

Enzymatic DNA synthesis company using TdT enzymes to write longer, higher-fidelity DNA; $68M Series B for synthetic biology and therapeutic applications.

45
AI Score
Grade C
AI Visibility Score (Beta)
HealthcareWebsiteUpdated March 2026

Company Overview

About Ansa Biotechnologies

Ansa Biotechnologies is a synthetic DNA synthesis company developing enzymatic DNA writing technology to overcome the length and quality limitations of chemical DNA synthesis. Founded in 2021 and headquartered in Emeryville, California, Ansa uses engineered terminal deoxynucleotidyl transferase (TdT) enzymes rather than phosphoramidite chemistry to build DNA strands, enabling synthesis of longer sequences with higher fidelity and fewer toxic reagents. The company emerged from research at UC Berkeley and Lawrence Berkeley National Laboratory.

Business Model & Competitive Advantage

The company raised $68 million in Series B funding in 2023, backed by investors including Data Collective (DCVC), The Engine, and Andreessen Horowitz Bio, to commercialize its enzymatic synthesis platform. Ansa's technology is particularly relevant for applications requiring long DNA fragments — synthetic biology gene construction, therapeutic oligonucleotides, and data storage — where conventional synthesis reaches length and error-rate ceilings. By 2024-2025, the company has been delivering custom DNA synthesis orders to pharmaceutical, agricultural biotech, and research customers.

Competitive Landscape 2025–2026

In 2025, Ansa Biotechnologies operates at a critical juncture in synthetic biology infrastructure, as the field requires DNA synthesis capabilities far exceeding what chemical methods can reliably deliver. The company competes with Twist Bioscience, Integrated DNA Technologies (IDT), and emerging enzymatic competitors like DNA Script. Ansa's 2025-2026 priorities include scaling throughput, pursuing FDA engagement for therapeutic oligonucleotide applications, and expanding into DNA data storage partnerships where unprecedented sequence lengths are commercially valuable.

Founded
2021
Headquarters
Emeryville, California
Curated content • Fact-checked and verified

Recent Activity

View all →

Key Differentiators

Strong Challenger

Ansa Biotechnologies is an established challenger with significant market presence and competitive offerings in Healthcare.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

45
→ Stable

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

Browser Use logo

Browser Use

Developer Tools
B2bDeveloper ToolsPlatformSaasStartup

Browser Use is an open-source project that provides a Python library allowing AI agents and large language models to control web browsers as a tool. The library sits between LLM APIs and browser autom

athenahealth logo

athenahealth

Healthcare
B2bCloud NativeEnterpriseErpHealthtechNorth AmericaSaas

athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on

Veeva Systems logo

Veeva Systems

Healthcare Tech
B2bHealthtechSaasPublic

Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv

Oracle Health logo

Oracle Health

Healthcare
HealthtechNorth AmericaB2b

Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve

Idexx Laboratories logo

Idexx Laboratories

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu

Revvity logo

Revvity

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid

For Ansa Biotechnologies

Claim This Profile

Are you from Ansa Biotechnologies? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Ansa Biotechnologies Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Ansa Biotechnologies vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →